The NADecNemab Biosimilar Anti-GFRA3 Antibody is a cutting-edge product designed for researchers studying the GFRA3 protein, a key molecule involved in nerve growth factor signaling. This biosimilar antibody, developed for use in various experimental applications, is manufactured to the highest standards to ensure consistent and reliable results.With its high specificity and sensitivity, the NADecNemab Biosimilar Anti-GFRA3 Antibody is an indispensable tool for investigating the role of GFRA3 in neural development, neurodegenerative diseases, and cancer.
By targeting GFRA3, researchers can gain valuable insights into its function and potential therapeutic applications.Whether you are conducting basic research or drug development studies, this antibody can help advance your understanding of GFRA3 biology and pave the way for innovative therapies targeting this important protein. Trust in the quality and performance of the NADecNemab Biosimilar Anti-GFRA3 Antibody for your next research endeavor.
Product Name:
Nadecnemab (Anti-GFRA3) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0083
Target:
GFRA3
Host Species:
Homo sapiens
Reactivity:
Human
Recommended Dilution:
ELISA 1:5000-10000; Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
REGN5069
Description:
Anti-GFRA3(nadecnemab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
ELISA, Flow Cyt
Antibody Isotype:
IgG4
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
